Back to Search
Start Over
Effects of the fluoroquinolone antibacterial drug ciprofloxacin on ventricular repolarization in the halothane-anesthetized Guinea pig
- Source :
- Journal of Pharmacological Sciences, Vol 122, Iss 3, Pp 205-212 (2013)
- Publication Year :
- 2013
-
Abstract
- The fluoroquinolone antibiotic ciprofloxacin has been reported to block delayed rectifier K+ channels at much higher concentrations than those at which it exerts its bactericidal activity. In this study using the halothane-anesthetized guinea pig, we assessed whether ciprofloxacin has a proarrhythmic activity. Ciprofloxacin at a clinically relevant dose of 3 mg/kg, i.v. did not affect any electrocardiographic parameters. At 10 mg/kg, it prolonged the QT interval and the duration of the monophasic action potential of the ventricle under sinus rhythm and constant ventricular pacing (n = 6). The extents of its effects on the ventricular repolarization phase were comparable to those of another fluoroquinolone antibiotic moxifloxacin at a clinically relevant dose of 3 mg/kg (n = 6). Meanwhile, the PR interval and QRS width were also increased by ciprofloxacin at 10 mg/kg, suggesting that the drug inhibited cardiac K+ channels as well as Na+ and Ca2+ channels in vivo. These results suggest that ciprofloxacin exerted a multi-ion channel–blocking action in the heart within the supra-therapeutic dose range. Therefore, careful observation may be necessary for patients with heart disease receiving a higher dose of ciprofloxacin in order to prevent the emergence of resistance. Keywords:: ciprofloxacin, fluoroquinolone antibiotic, QT interval, monophasic action potential
- Subjects :
- Heart Ventricles
Guinea Pigs
Action Potentials
Pharmacology
QT interval
Electrocardiography
Fluoroquinolone Antibiotic
Sodium channel blocker
Moxifloxacin
Ciprofloxacin
Drug Resistance, Bacterial
Potassium Channel Blockers
Medicine
Animals
Ventricular Function
Sinus rhythm
Anesthesia
PR interval
Dose-Response Relationship, Drug
business.industry
lcsh:RM1-950
Calcium Channel Blockers
Anti-Bacterial Agents
Long QT Syndrome
lcsh:Therapeutics. Pharmacology
Molecular Medicine
Halothane
business
medicine.drug
Sodium Channel Blockers
Subjects
Details
- ISSN :
- 13478648
- Volume :
- 122
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Journal of pharmacological sciences
- Accession number :
- edsair.doi.dedup.....3e77b3d06cb667b73943b3f6ee3da99a